Medicare coverage of investigational devices with "incremental risk" to begin Nov. 1.
This article was originally published in The Gray Sheet
Executive Summary
MEDICARE COVERAGE OF INVESTIGATIONAL DEVICES PRESENTING "INCREMENTAL RISK" relative to an approved device will begin Nov. 1, 1995. Faced with pressure from Capitol Hill, the medical device and hospital industries, and physicians, HCFA plans to issue a final rule in the Sept. 19 Federal Register that partially reverses its policy of refusing to pay for unapproved devices in investigational device exemption trials. There will be a 60-day comment period on the final rule.
You may also be interested in...
CMS Should Clarify Coverage For Device Trials, Manufacturers Say
Device manufacturers are asking for a clearer path to Medicare coverage of their clinical studies
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”